1.60
2.44%
-0.04
시간 외 거래:
2.58
0.98
+61.25%
Pharmacyte Biotech Inc (PMCB) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
32.59%
1.8689
|
1.4095 | 2.0753 | 0.9033 | 1.553 |
Operating Income/Loss |
32.59%
-1.8689
|
-1.4095 | -2.0753 | -0.9033 | -1.553 |
Nonoperating Income/Loss |
70.25%
1.2494
|
4.1994 | -1.108 | 0.7769 | 0.7888 |
Income/Loss From Continuing Operations Before Tax |
122.21%
-0.6195
|
2.7899 | -3.1833 | -0.1263 | -0.7641 |
Income/Loss From Continuing Operations After Tax |
122.21%
-0.6195
|
2.7899 | -3.1833 | -0.1263 | -0.7641 |
Net Income/Loss
|
122.21%
-0.6195
|
2.7899 | -3.1833 | -0.1263 | -0.7641 |
Preferred Stock Dividends And Other Adjustments |
5.0006
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.80%
8.607
|
8.7651 | 12.60 | -0.5624 | 19.00 |
Diluted Average Shares |
1.80%
8.607
|
8.7651 | 12.60 | -0.5624 | 19.00 |
Basic Earnings Per Share |
150.00%
-0.65
|
-0.26 | -0.28 | -0.01 | -0.04 |
Diluted Earnings Per Share |
150.00%
-0.65
|
-0.26 | -0.28 | -0.01 | -0.04 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
5.0006
|
- | - | - | - |
자본화:
|
볼륨(24시간):